Unknown

Dataset Information

0

Active Component of Antrodia cinnamomea Mycelia Targeting Head and Neck Cancer Initiating Cells through Exaggerated Autophagic Cell Death.


ABSTRACT: Head and neck squamous cell carcinoma (HNSCC) is a highly lethal cancer. Previously, we identify head and neck cancer initiating cells (HN-CICs), which are highly tumorigenic and resistant to conventional therapy. Therefore, development of drug candidates that effectively target HN-CICs would benefit future head and neck cancer therapy. In this study, we first successfully screened for an active component, named YMGKI-1, from natural products of Antrodia cinnamomea Mycelia (ACM), which can target the stemness properties of HNSCC. Treatment of YMGKI-1 significantly downregulated the aldehyde dehydrogenase (ALDH) activity, one of the characteristics of CIC in HNSCC cells. Additionally, the tumorigenic properties of HNSCC cells were attenuated by YMGKI-1 treatment in vivo. Further, the stemness properties of HN-CICs, which are responsible for the malignancy of HNSCC, were also diminished by YMGKI-1 treatment. Strikingly, YMGKI-1 also effectively suppressed the cell viability of HN-CICs but not normal stem cells. Finally, YMGKI-1 induces the cell death of HN-CICs by dysregulating the exaggerated autophagic signaling pathways. Together, our results indicate that YMGKI-1 successfully lessens stemness properties and tumorigenicity of HN-CICs. These findings provide a new drug candidate from purified components of ACM as an alternative therapy for head and neck cancer in the future.

SUBMITTER: Chang CW 

PROVIDER: S-EPMC3703405 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Active Component of Antrodia cinnamomea Mycelia Targeting Head and Neck Cancer Initiating Cells through Exaggerated Autophagic Cell Death.

Chang Ching-Wen CW   Chen Chien-Chih CC   Wu Meng-Ju MJ   Chen Yu-Syuan YS   Chen Chin-Chu CC   Sheu Sen-Je SJ   Lin Ting-Wei TW   Chou Shiu-Huey SH   Lin Shu-Chun SC   Liu Chung-Ji CJ   Lee Te-Chang TC   Huang Chih-Yang CY   Lo Jeng-Fan JF  

Evidence-based complementary and alternative medicine : eCAM 20130612


Head and neck squamous cell carcinoma (HNSCC) is a highly lethal cancer. Previously, we identify head and neck cancer initiating cells (HN-CICs), which are highly tumorigenic and resistant to conventional therapy. Therefore, development of drug candidates that effectively target HN-CICs would benefit future head and neck cancer therapy. In this study, we first successfully screened for an active component, named YMGKI-1, from natural products of Antrodia cinnamomea Mycelia (ACM), which can targe  ...[more]

Similar Datasets

| S-EPMC5341960 | biostudies-literature
| S-EPMC9946338 | biostudies-literature
| S-EPMC6258711 | biostudies-literature
| S-EPMC7228547 | biostudies-literature
| PRJNA924494 | ENA
| PRJNA923766 | ENA
| PRJNA923826 | ENA
| S-EPMC3942906 | biostudies-literature
| S-EPMC7350611 | biostudies-literature
| S-EPMC5598227 | biostudies-literature